Skip to main content
Rapid Dose Therapeutics Corp logo

Rapid Dose Therapeutics Corp — Investor Relations & Filings

Ticker · DOSE ISIN · CA75339A1012 CSE Manufacturing
Open in API
Filings indexed 490 across all filing types
Latest filing 2023-01-10 Regulatory Filings
Country CA Canada
Listing CSE DOSE

About Rapid Dose Therapeutics Corp

https://rapid-dose.com/

Rapid Dose Therapeutics Corp. is a pharma-technology company specializing in proprietary drug delivery technologies engineered to enhance patient outcomes and quality of life. The core business revolves around an innovative oral delivery platform utilizing sublingual thin film strip technology. The company's flagship product, QuickStrip™, is a fast-dissolving system designed for the rapid release of pharmaceuticals, micronized oils, and over-the-counter medicines. QuickStrip™ is distinguished by its ability to achieve blood concentrations comparable to intravenous injection, offering superior bioavailability and rapid onset. RDT provides product innovation, production, and consultation services to the pharmaceutical and healthcare manufacturing sectors for both prescription and non-prescription applications.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Rapid Dose Therapeutics providing an update on a failure to file cease trade order (FTFCTO) issued by the Ontario Securities Commission (OSC). It discusses delays in filing the company's annual financial statements for the fiscal year ended February 28, 2022, as well as interim financial statements. The document references regulatory filings, management cease trade orders, and the status of required filings but does not contain the actual financial statements or detailed financial data. It is an announcement about the status of filings and regulatory compliance rather than the filings themselves. Therefore, it fits best as a Regulatory Filings (RNS) type, which covers general regulatory announcements and compliance updates that do not fit other categories.
2023-01-10 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Rapid Dose Therapeutics providing an update on a failure to file cease trade order (FTFCTO) issued by the Ontario Securities Commission (OSC). It discusses delays in filing the company's annual financial statements for the fiscal year ended February 28, 2022, as well as interim financial statements. The document references regulatory filings, management cease trade orders, and the status of required filings but does not contain the actual financial statements or detailed financial data. It is an announcement about the status of filings and regulatory compliance rather than the filings themselves. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance updates that do not contain substantive financial reports.
2022-12-30 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Rapid Dose Therapeutics providing an update on a failure to file cease trade order issued by the Ontario Securities Commission. It discusses delays in filing the company's annual financial statements for the fiscal year ended February 28, 2022, as well as interim financial statements. The document references regulatory actions, filing deadlines, and the status of these filings but does not contain the actual financial statements or detailed financial data. It is an announcement about regulatory compliance issues and filing delays rather than the financial report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-12-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Rapid Dose Therapeutics providing an update on a failure to file cease trade order issued by the Ontario Securities Commission due to delays in filing the company's annual financial statements and interim financial statements. It discusses regulatory actions, filing deadlines, and the status of the filings but does not contain the actual financial statements or detailed financial data. The document is an announcement about regulatory compliance issues and filing delays rather than the financial reports themselves. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit into other specific categories.
2022-12-13 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Rapid Dose Therapeutics providing an update on a failure to file cease trade order (FTFCTO) issued by the Ontario Securities Commission (OSC). It discusses delays in filing the company's annual financial statements for the fiscal year ended February 28, 2022, as well as interim financial statements and related certifications. The document references regulatory filings and deadlines but does not contain the actual financial statements or detailed financial data. It is an announcement about the status of filings and regulatory compliance rather than the filings themselves. Therefore, it fits best as a Regulatory Filings (RNS) type, which covers general regulatory announcements and compliance updates that do not fit other categories.
2022-11-30 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Rapid Dose Therapeutics providing an update on a failure to file cease trade order issued by the Ontario Securities Commission due to delays in filing the company's annual financial statements and interim financial statements. It discusses regulatory actions, filing deadlines, and extensions but does not contain the actual financial statements or detailed financial data. The document is an announcement about regulatory compliance status and filing delays rather than the financial reports themselves. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-11-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.